NEWS

Publications

04.07.2022

The Anti-histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits SARS-CoV-2 Infection in Reconstituted Human Nasal Tissue In Vitro. Read more

Press Releases

20.04.2020

CALYXHA announces grant of a European Patent on neurodegenerative diseases. Read more

04.03.2020

CALYXHA endeavors to develop novel approaches to tissue degenerative diseases and receives support from Austrian VC and international investors. Read more

 © Calyxha Biotechnologies GmbH 2022   |    All Rights Reserved    |     Impressum    |     Privacy policy

  • LinkedIn